For healthcare diagnostics India is a very potential opportunity. Growing incidence of lifestyle diseases, rising demand for affordable healthcare delivery systems due to the increasing healthcare costs, technological advancements, the emergence of telemedicine, rapid health insurance penetration, and government initiatives like e-health together with tax benefits and incentives are driving the healthcare market in India.
By 2020, India is expected to rank amongst the top 3 healthcare markets in terms of incremental growth, By 2020, the healthcare information technology market is expected to grow 1.5 times from current $1 bn, By 2022, the diagnostics market is expected to grow at a CAGR of 20% to reach $32 bn from $5 bn in 2012, During 2015-20, the in-patient market is expected to grow at a CAGR of 13%.
Lilac Insights is one of India’s leading Genetic Health Assessment & Diagnostic Centre. With pan-India presence and covering over 250+ cities. Presently our focus is focused in Reproductive Genetics, Onco Genetics, Genetic Counseling and Metabolic Genetics.
Our testing services are trusted by over 7000+ specialists and super-specialist clinicians like Fetal medicine specialist, Obstetricians- Gynaecologists, Radiologists, Oncologists, Pediatricians, Clinical Geneticists across India. We have the largest network of Key Opinion Leaders in the country who use our services regularly.
We are looking for collaborations/partnerships with specialized Diagnostic partners who have unique genomic tests that can make a significant impact in clinicians' practice in India. Lilac Insights can provide quality market access to our potential partners.
Get ready to join hands with one of India’s leading Genetic Diagnostic Company.
Some of our earlier and present renowned partners are: